Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China flag China · Delayed Price · Currency is CNY
16.48
-0.13 (-0.78%)
Nov 18, 2026, 3:00 PM CST

SHA:600521 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,1841,5041,5371,3421,3651,876
Trading Asset Securities
79.3275.9860.7993.04143.071.01
Cash & Short-Term Investments
2,2641,5801,5971,4351,5081,877
Cash Growth
49.69%-1.07%11.28%-4.82%-19.66%-15.13%
Accounts Receivable
3,2723,1723,2352,5572,8311,906
Other Receivables
2440.0438.7628.447.4340.85
Receivables
3,2963,2123,2742,5852,8791,947
Inventory
3,6333,7123,4133,4323,3752,739
Prepaid Expenses
--5.114.25--
Other Current Assets
247.85237.32193.06164.61145.35250.18
Total Current Assets
9,4418,7428,4837,6227,9076,813
Property, Plant & Equipment
9,6169,4728,5717,9947,3075,961
Long-Term Investments
815.5770.06796.17785.25863.171,027
Goodwill
65.8464.4564.4564.4570.970.9
Other Intangible Assets
1,1691,1581,1961,1131,072970.6
Long-Term Deferred Tax Assets
188.54194.78189.67171.99183.9110.15
Long-Term Deferred Charges
1,1801,098960.16843.04737.88508.28
Other Long-Term Assets
5.792.931.096.459.467.87
Total Assets
22,48221,50320,26118,60018,15215,468

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,4471,8071,5851,3871,203881.79
Accrued Expenses
183.73907.8997.44735.43898.42791.6
Short-Term Debt
2,6282,8602,1101,5831,3971,314
Current Portion of Long-Term Debt
2,5893,231943.471,191630.76630.99
Current Portion of Leases
-29.2914.1116.8216.7213.82
Current Income Taxes Payable
160.9636.3981.6891.14264.11187.9
Current Unearned Revenue
46.3434.9954.433.5167.766.71
Other Current Liabilities
819.28205.22189.5407.71321.64348.93
Total Current Liabilities
7,8749,1125,9765,4454,7994,236
Long-Term Debt
3,3101,8414,3944,0224,6783,498
Long-Term Leases
6.3475.6416.9944.9359.1466.41
Long-Term Unearned Revenue
646.81661.84698.95665.44532.09448.44
Other Long-Term Liabilities
306.86356.02155.9171.02338443.51
Total Liabilities
12,14412,04711,24110,34910,4068,692

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,4971,4971,4671,4831,4831,492
Additional Paid-In Capital
1,3401,6101,1851,2961,3221,381
Retained Earnings
7,1066,1956,3015,4704,9923,971
Treasury Stock
-100.01-100.01-300.05-416.91-484.25-521.84
Comprehensive Income & Other
220.97240.17244.47244.43233.98236.54
Total Common Equity
10,0649,4438,8988,0777,5476,559
Minority Interest
273.5413.35122.25174.26199.07217.48
Shareholders' Equity
10,3389,4569,0208,2517,7466,776
Total Liabilities & Equity
22,48221,50320,26118,60018,15215,468

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
8,5338,0387,4786,8586,7825,523
Net Cash (Debt)
-6,269-6,457-5,881-5,422-5,273-3,646
Net Cash Growth
------
Net Cash Per Share
-4.17-4.36-4.05-3.72-3.61-2.54
Filing Date Shares Outstanding
1,4901,4901,4491,4681,4731,484
Total Common Shares Outstanding
1,4901,4901,4491,4681,4731,484
Working Capital
1,567-370.112,5072,1763,1092,577
Book Value Per Share
6.596.185.975.344.964.26
Tangible Book Value
8,8298,2207,6376,8996,4035,517
Tangible Book Value Per Share
5.765.355.104.544.183.56
Buildings
-5,5234,5273,7572,8392,151
Machinery
-6,9906,2285,546152.083,827
Construction In Progress
-1,9872,1882,3172,8032,502